Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy: Shorter stay, earlier catheter removal and fewer complications

BJU International

Volumn 95, Issue 1, 2005, Pages 69-71

  Starkman, Jonathan S ^a   Santucci, Richard A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar; Gyrus; Transurethral resection of prostate

Indexed keywords

FUROSEMIDE; PROSTATE SPECIFIC ANTIGEN; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BALLOON CATHETER; CLINICAL ARTICLE; CONTRACTURE; CONTROLLED STUDY; COST CONTROL; DIGITAL RECTAL EXAMINATION; FOLLOW UP; HUMAN; HYPONATREMIA; INTERMETHOD COMPARISON; LENGTH OF STAY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RETROSPECTIVE STUDY; STRESS INCONTINENCE; SURGICAL TECHNIQUE; TRANSURETHRAL RESECTION; URETHRA STRICTURE; URETHROTOMY; URINE CATHETER; URINE RETENTION; BIPOLAR TRANSURETHRAL RESECTION; CATHETER REMOVAL; MAJOR CLINICAL STUDY; MICTURITION DISORDER; PROSTATECTOMY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; COST SAVINGS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; TRANSURETHRAL RESECTION OF PROSTATE; URINARY CATHETERIZATION; URINARY RETENTION;

EID: 12544254190     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05253.x     Document Type: Article

References (10)

1. Roberts RO, Jacobsen SJ, Jacobson DJ, Reilly WT, Talley NJ, Lieber MM. Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence. Urology 1994; 43: 621-8
2. Roehrborn CG, McConnell J, Bonilla J et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol 2000; 163: 13-20
3. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995; 332: 75-9
4. AUA Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia. Chapter 1: Diagnosis and treatment recommendations. J Urol 2003; 170: 530-74
5. Gee WF, Holtgrewe HL, Albertsen PC et al. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. J Urol 1995; 154: 205-6
6. McCullough DL. Minimally invasive treatment of benign prostatic hyperplasia. In Walsh P, Retik AB, Vaughan ED, Wein A eds, Campbell's Urology, Vol. 2, 7th edn. Philadelphia: WB Saunders, 1998: 1479-509
7. Botto H, Lebret T, Barre P, Orsoni JL, Herve JM, Lugagne PM. Electrovaporization of the prostate with the Gyrus device. J Endourol 2001; 15: 313-6
8. Dunsmuir WD, McFarlane JP, Tan A et al. Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up. Prostate Cancer Prostatic Dis 2003; 6: 182-6
9. Nesbit RM. Transurethral Prostatectomy. Springfield IL: CC Thomas, 1943
10. Perrin P, Barnes R, Hadley H, Bergman RT. Forty years of transurethral prostatic resections. J Urol 1976; 116: 757-8